Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1592 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Illumina Begins Omni2.5 BeadChip Shipments

Illumina said that the array provides up to 50% more coverage of human genome variation. The Omni2.5 delivers genome coverage for both SNP and copy number variation (CNV)

Akela Pharma Q4 Revenues Down

Akela Pharma has posted a net income of $14.06m, or $0.46 per diluted share, compared $13.6m, or $0.63 per diluted share, for the prior year period. For the

BTS Opens New Regional Office In Brazil

Reportedly, the new office is located at Av. das Americas, 500, Downtown Bloco 11, Loja 108, 26640-100 Rio de Janeiro (RJ), Brazil. The new BTS office is headed

Dendreon Presents Provenge Safety Data

Dendreon said that Provenge is the first autologous cellular immunotherapy to be approved by the FDA for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone

Health Canada Approval For Aurobindo Cefotaxime Sodium

Cefotaxime sodium for injection is the generic equivalent of Canadian reference product Claforan tablets of Sanofi-Aventis, Canada. Cefotaxime sodium falls under the anti-infective therapeutic segment and is indicated